Lansforsakringar Fondforvaltning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5M Buy
325,753
+210,131
+182% +$17M 0.11% 143
2026
Q1
$10M Sell
115,622
-4,351
-4% -$417K 0.05% 280
2025
Q4
$11.5M Buy
119,973
+112,331
+1,470% +$10.9M 0.06% 264
2025
Q3
$728K Sell
7,642
-158
-2% -$14.5K ﹤0.01% 509
2025
Q2
$680K Sell
7,800
-19,655
-72% -$1.67M ﹤0.01% 517
2025
Q1
$2.47M Sell
27,455
-5,076
-16% -$454K 0.02% 479
2024
Q4
$2.6M Buy
+32,531
New +$2.82M 0.01% 479

Other funds holding MDT

Lansforsakringar Fondforvaltning's MDT Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its Medtronic (MDT) stake by 182% in Q2 2026, buying an estimated $17M and bringing the position to 325,753 shares worth $25.5M. The position accounts for 0.11% of the portfolio, ranked #143.

Lansforsakringar Fondforvaltning first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 325,753 shares of Medtronic worth $25.5M as of Q2 2026.
  • Lansforsakringar Fondforvaltning bought 210,131 Medtronic shares in Q2 2026, an estimated $17M.
  • Medtronic made up 0.11% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #143 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.